Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MFAP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ADD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRSF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIN2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927933 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAX8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPAG8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABLIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOC6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NT5C3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A48 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GLIS3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXW8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on